Short-Term Outcomes of Impella Support in Japanese Patients With Cardiogenic Shock Due to Acute Myocardial Infarction ― Japanese Registry for Percutaneous Ventricular Assist Device (J-PVAD) ―

Yuki Ikeda, Junya Ako, Köichi Toda, Atsushi Hirayama, Koichiro Kinugawa, Yoshio Kobayashi, Minoru Ōno, Takashi Nishimura, Naoki Sato, Takahiro Shindo,

Circulation Journal · 2023 · 61 citations · 20 references

DOIFull text

Open access

Abstract

AMICS treatment with Impella showed favorable 30-day survival and safety profiles. The survival rate of patients treated with Impella alone was particularly high. Further studies are needed to improve outcomes of patients with ECPELLA support.

References

20